Actively Recruiting
Radiology Registry on Pancreatic Malignancies
Led by IRCCS San Raffaele · Updated on 2024-04-12
1300
Participants Needed
1
Research Sites
156 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This research aims to collect radiological and clinical data to better understand the malignancy and prognosis of pancreatic diseases, including pancreatic cancer and other pancreatic neoplasms. It involves both retrospective data from 2014 and prospective data collection until 2027, with follow-up lasting up to 3 years per patient. The study is observational and non-randomized, reflecting ordinary therapeutic strategies decided by multidisciplinary teams for each patient. Participants undergo various diagnostic and interventional radiology procedures as part of their usual care. These procedures are not assigned by the study but are recorded along with clinical outcomes such as progression-free survival, local progression-free survival, and overall survival to assess the impact on pancreatic neoplasms. The study will continue to collect data and monitor patients over time to evaluate these outcomes. During the study, participant data including radiology scans and clinical progress are collected and analyzed. Researchers will review survival outcomes and treatment responses over a maximum period of three years. The study involves no experimental treatment but focuses on gathering comprehensive clinical and radiological information to improve understanding of pancreatic disease progression and treatment effects.
CONDITIONS
Brief Title
Radiology Registry on Pancreatic Malignancies
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 years of age or older
- Patients with suspected or diagnosed pancreatic cancer at any stage
- Able and willing to sign informed consent
You will not qualify if you...
- Patients with non-primary pancreatic disease
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Ongoing as clinically indicated
Participants undergo diagnostic radiology procedures as part of their routine clinical care to assess pancreatic malignancies.
Visits depending on clinical need
Duration - Up to 3 years
Participants are observed over time to assess clinical outcomes such as progression-free survival and overall survival following their diagnostic and therapeutic procedures.
Follow-up visits as part of routine care
Trial Site Locations
Total: 1 location
1
Department of Radiology, IRCCS Ospedale San Raffaele
Milan, Italy, 20132
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here